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Results
Three eligible studies were identified, two cohort and one case-
control, based on the criteria identified in the method section. All 
studies considered hyponatremia in the context of elderly patients 
taking SSRI antidepressant medications. One study explicitly 
considered the relative incidence of hyponatremia in patients 
taking SSRIs and TCAs for depression. Each study shows 
increased odds or hazard ratios for hyponatremia in the setting of 
SSRI use by elderly patients, and the one study that examines TCA 
use by the elderly finds no significant increase in hyponatremia. 
The studies' GRADE criteria are summarized in Table I, and their 
findings are summarized in Table II.
Each study found a positive association between SSRI use and 
new onset hyponatremia in elderly patients.  The Coupland et al1 
study additionally identified a dose-response curve for SSRIs, no 
statistically significant association between TCA use and 
hyponatremia, and an increased all-cause mortality for elderly 
patients using SSRIs vs. TCAs for uncomplicated depression.
Discussion 
The lack of studies revealed by the literature search between the 
Kirby et al2 and Movig et al3 studies, both of which were published 
in 2002, and the study by Coupland et al1 published in 2011 is 
perplexing.  Both 2002 studies2,3 are of modest methodological 
quality per GRADE evaluation (see Table I), which is entirely 
excusable in that each builds on a body of previous topical 
literature primarily comprising case studies.  Indeed, just under 
half of the references identified for detailed scrutiny in the 
literature search were eliminated because they were case studies.  
Of those, roughly two-thirds were published between 2003 and 
2011, so the publication of such case studies clearly did not end 
with the Kirby et al2 and Movig et al3 study publications.
The dearth of published studies using incrementally improving 
levels of evidence for the association between SSRIs and 
hyponatremia is accompanied by a broadening of the literature in 
which articles providing such modest levels of evidence are found: 
general geriatric and nursing journals are replete with such case 
studies.  One explanation for the lack of progression is that the 
evidence was considered adequate to prompt surveillance, but not 
sufficiently actionable to modify clinical practice.
SSRIs, as a class, have many things to commend them over TCAs 
for the treatment of depression.  Hyponatremia is not an infrequent 
problem in an elderly population, even in the absence of SSRIs, 
and as such focusing on SSRI-associated hyponatremia may 
simply not have been deemed worthy of further investigation.  
That is, the association may have entered clinical consciousness 
without a rigorous investigation of the causal relationship, 
potential etiologies, or overall public health impacts. Likewise, it 
is possible that clinicians are currently finding hyponatremia as the 
literature would suggest, and either treating it appropriately, or 
monitoring it without intervention when the intervention would be 
deemed riskier than stable, asymptomatic hyponatremia.
Background
Hyponatremia has been associated with antidepressant 
use in the elderly.  It is prompted by multiple classes of 
medications, and rates of hyponatremia are higher in elderly 
patients.  As the elderly population grows worldwide, the 
potential for significant rates of otherwise avoidable 
morbidity and mortality due to the antidepressant-related 
hyponatremia experiences commensurate growth.  Tricyclic 
antidepressants (TCAs) were dethroned as the first-line drug 
class for uncomplicated depression by the newer class of 
selective serotonin reuptake inhibitors (SSRIs) in the 1990s, 
as illustrated in Figure I.  At the time, patients started on 
SSRIs for depression experienced fewer immediate adverse 
drug reactions. However, current research suggests that 
TCAs may be associated with fewer negative outcomes. 
This review focuses on the relative risk of one such 
outcome, hyponatremia, in elderly patients with depression 
using SSRIs vs those treated with TCAs.  It additionally 
considers all-cause mortality in the same patient population 
to the extent identified studies examine that question.
Method
An exhaustive search of available medical literature was 
conducted in MEDLINE, CINAHL, and EBMR Multifile 
for records which referenced: hyponatremia or 
inappropriate antidiuretic hormone (ADH) syndrome; 
depression, “antidepressant agents, tricyclic”, or serotonin 
reuptake inhibitors; and an aged population. Results were 
limited to English-language studies on humans published 
since 2002.   Additional relevant records were found by 
using Web of Science's citation-finding tool to identify 
additional articles citing those found in the initial search. Conclusion
SSRIs appear to have more potential for antidepressant-associated hyponatremia in elderly patients than do 
TCAs.  While the patient-obvious adverse drug reactions are clearly less with SSRIs than TCAs, hyponatremia and 
all cause mortality appear to be substantially higher. Further research is needed to quantify the relative harms 
between SSRIs and TCAs so that clinicians and patients can make informed decisions about the relative risks and 
benefits of these two antidepressant classes. This objective would be most readily accomplished by randomized 
controlled trials directly comparing these two drug classes in elderly patients with depression. Since SSRIs will 
remain a staple antidepressant class for the foreseeable future, clinicians should remain vigilant for hyponatremia 
in elderly patients recently started on SSRIs.
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Study Year Design Limitations of 
Methodology
Inconsistency Indirectness Imprecision Publication 
Bias
Factors that 
increase 
confidence
Sample 
Size
Quality
Coupland et 
al1
2011 Retrospective 
cohort
None Identified None Identified None Identified None Identified None Identified Dose-response 
gradient
60746 Moderate
Kirby et al2 2002 Retrospective 
cohort
None Identified None Identified Does not consider 
TCA
Sample size 
<300
None Identified None 199 Low
Movig et al3 2002 Retrospective 
Case-Control
Did not examine 
mildly 
hyponatremic 
patients with serum 
Na 131-135.
None Identified Not exclusively an 
elderly population. 
Does not separate out 
TCAs, lumping them 
in with  “other 
antidepressants”
Sample size 
<300
None Identified None 107 Very Low
Table I. Characteristics of Reviewed Studies
Table II. Summary of Findings
Study Year Design Population Age Range Serious mental 
illness
Comparison Result* 95% CI
Coupland et al1 2011 Retrospective 
cohort
60746 65-99 0% All-cause mortality in TCA-users vs. no antidepressant use HR 1.16 1.10-1.22
All-cause mortality in SSRI-users vs. no antidepressant use HR 1.54 1.48-1.59
Hyponatremia in TCA users vs. no antidepressant use HR 1.05 0.87-1.27**
Hyponatremia in SSRI users vs. no antidepressant use HR 1.52 1.33-1.75
Kirby et al2 2002 Retrospective 
cohort
199 60-100 (mean 
74.2)
46%
(92/199)
Hyponatremia in SSRI/Venlafaxine vs. other antidepressants OR 3.5 1.4-8.9
107 unspecified 0% Hyponatremia in SSRI/Venlafaxine vs. other 
antidepressants, restricted to patients with depression alone
OR 3.1 1.1-8.6
Movig et al3 2002 Retrospective case-
control
107 >18 years 
(mean 68)
unspecified Hyponatremia in SSRI vs. other antidepressants OR 3.9 1.2-13.1
49 >= 65 years unspecified Hyponatremia in SSRI vs. other antidepressants, restricted 
to age 65 or older
OR 6.3 1.0-41
* All results listed as adjusted by the methodologies of their respective studies.
** Not significant.
Reproduced from Coupland CAC, Dhiman P, Barton G, et al. A study of the safety and harms of antidepressant drugs for older people: 
a cohort study using a large primary care database. Health Technol Assess. 2011;15:25. (c) 2011 Queen's Printer and Controller of 
HMSO, used by permission.
Figure II: Percentages of Prescription for Each 
Antidepressant Class by Year of Prescription
